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INTRODUCTION 
Marine macroalgae or seaweeds synthesize a wide variety of polymers and smaller compounds with 
several bioactivities, among which the sulfated polysaccharides acquire greater relevance not only due to 
the reported antioxidant, antiviral and anticancer1 activities, but also to the resemblance of extracellular 
matrix glycosaminoglycans found in the human body2. 
In this study, the potential of fucoidan (Fu) isolated from brown seaweed Fucus vesiculosus for 
therapeutical use has been evaluated, focusing in its performance as antitumoral agent (bioactive role) or 
as building block of cell encapsulating systems (structural role). 
 
MATERIALS AND METHODS 
The anticancer activity of Fu extracts was assessed by evaluating the cytotoxic behavior over two human 
breast cancer cell lines (MCF-7 and MDA-MB-231) in in-vitro culture, using human fibroblasts and 
endothelial cells (HPMEC-ST1 and MRC-5, respectively) as reference. 
Regarding the structural role, Fu was modified by methacrylation reaction (MFu) using methacrylic acid 
and further crosslinked using visible radiation and triethanolamine and eosin-y as photoinitiators. The 
photocrosslinking was performed on MFu solution droplets placed in a silica-based superhydrophobic 
surface3, allowing the formation of particles4 (since natural Fu is highly soluble in water and ion gelation 
is not effective). Biological performance of the developed particles was assessed by in vitro culture of 
fibroblasts and pancreatic cells (L929 and 1.1B4, respectively) in contact with MFu particles, up to 7 days. 
The ability of the developed materials to support adhesion and proliferation of cells was evaluated for both 
types of cells. 
 
RESULTS AND DISCUSSION 
The tested anticancer activity is not ubiquitous on Fu extracts, being dependent on its chemical features, 
with molecular weight (Mw) representing a particular role. Specifically, Mw values around 60 kDa 
exhibited cytotoxic effects to human breast cancer cell lines, while not affecting normal fibroblasts or 
endothelial cells (which represent the cells of the healthy tissue that would be closer to the tumor in a real 
situation). A concentration range of 0.2 to 0.3 mg mL-1 from the selected Fu extract could be considered as 
the therapeutic window for further studies. 
Regarding fucoidan’s role on innovative biomaterials, the developed MFu particles could support the 
proliferation of fibroblasts (L929), but also of human pancreatic beta cells (1.1B4), which tend to form 
pseudo-islets after 7 days in culture (Fig. 1). This pancreatic cells could be also successfully encapsulated, 
opening a new route for a diabetes mellitus type 1 therapeutic approach. 
 
  
 
 
CONCLUSION 
The present work establishes fucoidan as a high performance building block for the development of 
advanced therapies for cancer (targeted therapy) or tissue and organ regeneration. It shed light on the 
relation between chemical structure and biological activity towards anti-cancer effect and proposes novel 
beta cell laden particles as injectable insulin producing systems to tackle diabetes. 
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Fig. 1: Confocal microscopy images of 1.1B4 cells cultured in the presence of 
fucoidan-based particles and organized in pseudo-islets (red – actin; blue – nuclei). 
